2027 ICD-10-CM Diagnosis Code G31.80Leukodystrophy, unspecified
ICD-10-CM Codes›G00–G99›G30-G32›G31
- Billable — Valid for Submission
- Risk Adjusts — HCC 200
- Chronic Condition
G31.80 is a billable ICD-10-CM diagnosis code for leukodystrophy, unspecified. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 56 through 57. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other nervous system disorders (often hereditary or degenerative).
For Medicare Advantage risk adjustment, G31.80 maps to CMS-HCC Category 200 (Friedreich and Other Hereditary Ataxias; Huntington Disease) under the V28 model, adding a risk factor of about 0.279 for a community, non-dual, aged beneficiary in payment year 2027.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
G31.80 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2027.
Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to G31.80: its own notes plus those printed at G31 and Chapter 6. A note printed at a category, block or chapter applies to every code under it.
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
- Reye's syndrome (G93.7)
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Use Additional Code
Add a second code, after this one, to fully describe the condition.
- code, if applicable, for codes G31.0-G31.83, G31.85-G31.9, to identify:
- dementia with anxiety (F02.84, F02.A4, F02.B4, F02.C4)
- dementia with behavioral disturbance (F02.81-, F02.A1-, F02.B1-, F02.C1-)
- dementia with mood disturbance (F02.83, F02.A3, F02.B3, F02.C3)
- dementia with psychotic disturbance (F02.82, F02.A2, F02.B2, F02.C2)
- dementia without behavioral disturbance (F02.80, F02.A0, F02.B0, F02.C0)
- mild neurocognitive disorder due to known physiological condition (F06.7-)
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name G31.80, its category, or a range that includes it.
Use Additional Code 1
These codes say to use an additional code from the note, and G31.80 is one of the codes named.
- G31 Other degenerative diseases of nervous system, not elsewhere classified
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Leukodystrophy G31.80
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Leukodystrophy
a group of rare genetic neurodegenerative disorders that affect infants and children. these disorders are characterized by metabolic abnormalities in the development of the myelin sheaths in the white matter. clinical signs and symptoms include developmental delays, mental retardation, dementia, seizures, loss of motor skills, and muscle weakness. representative examples include metachromatic leukodystrophy, krabbe disease, canavan disease, and alexander disease.
Patient EducationClinical
Leukodystrophies
Leukodystrophies are a group of rare genetic disorders that affect the central nervous system (CNS). The CNS is made up of your brain and spinal cord. Leukodystrophies damage the white matter of your CNS. The white matter includes:
The full article covers:
- What are leukodystrophies?
- What causes leukodystrophies?
- What are the symptoms of leukodystrophies?
- How are leukodystrophies diagnosed?
- What are the treatments for leukodystrophies?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Code History & ChangesHistory
Replacement G31.80 replaces the following previously assigned code(s):
- G31.89 - Other specified degenerative diseases of nervous system
Questions About G31.80Overview
What is the ICD-10 code for leukodystrophy, unspecified?
The ICD-10-CM code for leukodystrophy, unspecified is G31.80 (sometimes written as G3180). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is G31.80 (Other specified degenerative diseases of nervous system) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report leukodystrophy, unspecified on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does G31.80 group to?
When leukodystrophy, unspecified is the principal diagnosis on an inpatient stay, it groups to MS-DRG 57, 56, with relative weights from 1.2835 to 2.2649 depending on complications. Higher weights mean higher Medicare reimbursement.
Does G31.80 need an additional code?
When the condition applies, yes. The Use Additional Code note at G31, which applies to G31.80, reads: code, if applicable, for codes G31.0-G31.83, G31.85-G31.9, to identify: dementia with anxiety (F02.84, F02.A4, F02.B4, F02.C4); dementia with behavioral disturbance (F02.81-, F02.A1-, F02.B1-, F02.C1-); dementia with mood disturbance (F02.83, F02.A3, F02.B3, F02.C3); dementia with psychotic disturbance (F02.82, F02.A2, F02.B2, F02.C2); dementia without behavioral disturbance (F02.80, F02.A0, F02.B0, F02.C0); and 1 more listed in the Instructional Notes section. The additional code is reported after G31.80.
What HCC is G31.80?
G31.80 (leukodystrophy, unspecified) maps to CMS-HCC Category 200 (Friedreich and Other Hereditary Ataxias; Huntington Disease), commonly written as HCC 200, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2027. It mapped to HCC 52 under the retired V24 model. It also maps in the ESRD (V21) and ESRD (V24) models. It does not map to any RxHCC in the Part D prescription drug model.
Does G31.80 risk-adjust for Medicare Advantage payment?
Yes. When documented and reported on a Medicare Advantage encounter, G31.80 adds a risk adjustment factor of about 0.279 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.000 to 0.428 depending on the payment segment). HCC 200 sits at the top of its hierarchy, so no other condition category supersedes it. See the full factor table on the HCC 200 category page.